RBBP8 and urinary bladder carcinoma: The research group led by Rose et al. suggested that RBBP8 was significantly hypermethylated in bladder cancer (BLCA) and was associated with more prolonged overall survival, and they indicated that it may be used as a complementary marker for the detection of BLCA in urine (Mijnes et al., 2018).